Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

Launched by CALIFORNIA PACIFIC MEDICAL CENTER RESEARCH INSTITUTE · Dec 13, 2012

Keywords

ClinConnect Summary

This clinical trial is studying the outcomes of a procedure called endoscopic resection, which is used to remove abnormal growths in the gastrointestinal (GI) tract. These growths can be either benign (not cancerous) or malignant (cancerous). The main goal of the trial is to see how effective this treatment is in completely removing these lesions and ensuring patients have a good recovery. Researchers will also look at different techniques used during the procedure, how often complications occur (like infection or bleeding), and patients' survival rates after one year.

To participate in this trial, individuals must be over 18 years old and have been referred for endoscopic treatment of their GI lesions. Unfortunately, patients who were not able to have the endoscopic procedure will not be included. If you join the trial, you can expect to undergo this minimally invasive procedure and be monitored for your recovery and any potential side effects. It's important to know that the trial is currently recruiting participants, so there may be an opportunity for eligible individuals to take part in this important research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients age \>18 years that have been referred for endoscopic treatment of GI lesions.
• Exclusion Criteria:
• • Patients for whom endoscopic treatment was not performed.